SCYX Q1 2022 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$38M

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$687,000-94.3% YoY

Gross Profit

$588,00085.6% margin

Operating Income

-$20M-2873.1% margin

Net Income

-$5M-793.4% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+15.1%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$922,000

Balance Sheet

Total Assets

$112M

Total Liabilities

$73M

Stockholders' Equity

$39M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$687,000	$12M	-94.3%
Gross Profit	$588,000	$12M	-95.1%
Operating Income	-$20M	-$2M	-1138.3%
Net Income	-$5M	-$5M	-16.6%

Revenue Segments

Product

$687,000100%